title: Gastrointestinal stromal tumor mesenchymal neoplasms: the offspring that choose the wrong path.
abstract: Gastrointestinal stromal tumors (GISTs) are relatively rare neoplasms of the gastrointestinal tract originating from the pluripotential mesenchymal stem cells, which differentiate into interstitial Cajal cells. They are usually located in the upper gastrointestinal track. These tumors are typically defined by the expression of c-KIT (CD117) and CD34 proteins in the tumor cells. A small percentage of these tumors is negative for c-KIT. The neoplasms are positive for platelet-derived growth factor α (PDGFα) mutations. In addition to PDGFRα mutations, wild-type c-KIT mutations can also be present. The therapeutic approach to locally developed gastrointestinal stromal tumors is surgical resection, either with open or laparoscopic surgery. In case of systemic disease, molecular pharmacologic agents such as imatinib and sunitinib are used for treatment. These agents block the signaling pathways of neoplastic-cell tyrosine kinases, interfering in their proliferation and causing apoptosis.
authors.affiliation: Surgery Department (National Health System), University General Hospital of Alexandroupolis, Alexandroupolis.
authors.forename: Nikolaos
authors.initials: N
authors.lastname: Machairiotis
authors.forename: Ioanna
authors.initials: I
authors.lastname: Kougioumtzi
authors.forename: Paul
authors.initials: P
authors.lastname: Zarogoulidis
authors.forename: Aikaterini
authors.initials: A
authors.lastname: Stylianaki
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Tsimogiannis
authors.forename: Nikolaos
authors.initials: N
authors.lastname: Katsikogiannis
keywords: GIST; PDGFRα; cancer pathways; interstitial cells of Cajal; mesenchymal stem cells